Baotou Dongbao Biotechnology Co., Ltd. was established in 1997 (formerly the Baiming Gelatin Factory in Donghe District, which was founded in 1960). It is a high-tech enterprise and a GEM listed company. It belongs to the biomedical and big health industry and is encouraged by the state. Strategic emerging industries for development. The company is mainly engaged in the research, development, production and sales of gelatin, collagen and its extended products. Gelatin is mainly used in downstream hollow capsules, health products, nutritious and healthy foods and other fields. The second part of the Pharmacopoeia gelatin (plasma gelatin) is mainly used in downstream medical (pharmaceuticals), and collagen is mainly used in downstream drugs, health products, nutritious and healthy foods. , beauty, industrial applications and other fields; Qingdao Yiqing Biotechnology Co., Ltd. (hereinafter referred to as "Yiqing Biotechnology"), a holding subsidiary of the company, is mainly engaged in capsule business, and its main products include gelatin hollow capsules, enteric gelatin hollow capsules, and hydroxyl Four series of methylcellulose hollow capsules and Pruland polysaccharide hollow capsules; Inner Mongolia Dongbao Datian Biotechnology Co., Ltd. is mainly engaged in organic fertilizer business, and its products mainly include water-soluble fertilizers and organic fertilizers.

After more than 60 years of technological innovation and market development, the company has developed into a well-known production and operation enterprise in the collagen industry. The products have developed and extended to broader application fields such as collagen, hollow capsules, and terminal products. The company's annual gelatin production capacity is 13,500 tons and collagen production capacity is 4,300 tons. Through continuous technological improvement and innovation over the years, it currently has the production technical capabilities of bone collagen, fish collagen and skin collagen. The gelatin production line has the production technical capabilities and production conditions of the second part of the Pharmacopoeia gelatin (plasma gelatin replacement), and the company's Pharmacopoeia II Gelatin (plasma gelatin) has been targeted for sale, realizing import substitution in this field. Yiqing Bio has an annual production capacity of 24 billion pills. Yiqing Bio is currently fully promoting the construction of the "New Hollow Capsule Intelligent Industrialization Project" and is planning and building a "New Hollow Capsule Intelligent Industrialization Expansion Project". After the project is put into production, Yiqing Bio will have an annual output of nearly 70 billion hollow capsules, and will become a professional hollow capsule production base with the highest single-unit production capacity, complete varieties and high intelligence.

The company has now built a strict and complete production quality management system, passed the certification of FSSC22000 food safety system and ISO14001 environmental management system, and completed the certification and review of ISO9001 quality management system; now has the qualifications for gelatin production for capsules and food production license ( Bone-containing, fish gelatin, animal and plant double protein products, etc.), food business license, feed production license (used to by-product calcium hydrogen phosphate), CNAS and other license qualification certificates; gelatin obtains the export EU health registration qualification and obtains European medicines The collagen peptide CEP-TSE (European Pharmacopoeia Applicability-Certification) certificate issued by the Quality Administration (EDQM) and the European Pharmacopoeia Applicability Double Certificate (Double TSE+CHEM). Gelatin and collagen peptides have been successfully registered with the US FDA, obtained a DMF registration number, and passed the US NSF-GMP certification. In addition, the company has participated in the drafting of the group standards for animal and plant double protein products, and has been released and implemented by the Baotou Food and Drug Industry Association. The subsidiary Yiqing Bio has taken the lead in organizing the formulation of product quality industry standards for gelatin hollow capsules for pharmaceutical auxiliary materials. The products have passed the US NSF certification, BRCGS certification, ISO9001 quality management system certification, and ISO14001 environmental management system certification.

The company and its subsidiaries have always attached great importance to the research and development and industrialization of new technologies and new processes in collagen and its extended industries. After years of technological investment and accumulation, the company and its subsidiaries have the first batch of China Light Industry Gelatin Key Laboratory, Inner Mongolia Autonomous Region Key Laboratory, Autonomous Region Enterprise Research and Development Center, Autonomous Region Enterprise Technology Center, Qingdao Yiqing Biotechnology Co., Ltd. Technology Center ( Provincial level), Qingdao Hollow Capsule Manufacturing Innovation Center (municipal level), Qingdao Hollow Capsule Engineering Research Center (municipal level), Baotou Rare Earth High-tech Zone Postdoctoral Research Workstation Enterprise Branch and other platforms. It has dozens of authorized patents and has rich technical reserves. The company and Yiqing Bio have gradually developed into more influential innovative and large-scale enterprises among domestic enterprises.

As one of the few domestic enterprises focusing on the entire natural collagen industry chain, Dongbao Bio has formed a production, research and development and sales service system for high-quality bone granule base-gelatin-collagen-nutritional health products/medicine materials, and has formed a good technical reserve over the years. , brand effect and customer reputation. With the expansion of collagen application fields, the improvement of sales channels, the increase in resources and the further improvement of brand awareness, especially as Qingdao Guoen Technology Co., Ltd. becomes the controlling shareholder of the company and further accelerates the implementation of the strategy. The business ushers in more development opportunities. Currently, the raw materials include "Jinlu" brand gelatin, "Yuansu" brand collagen, "Baiyun" brand bone source calcium hydrogen phosphate, etc. The terminal series has successively launched the "Yuansu" brand of beef collagen peptide powder, fish collagen peptide powder, collagen hyaluronate sodium vitamin C powder, collagen peptide blueberry juice drink, collagen hand-pulled meat, and compound probiotic solid beverage , Bird's nest collagen peptide liquid drink, passion fruit enzyme powder, collagen moisturizing mask, bright color mask, etc.; the product categories have covered health foods, nutritional proteins, nourishing nutrition, intestinal management, and weight management , beauty and skin care, leisure snacks, etc. can meet the diverse health needs of people of different age groups.

The company will continue to focus on the collagen industry, closely focus on "collagen+", innovatively promote the in-depth application and layout of collagen in "medical, health, food, and beauty", launch the industrial integration strategy in a timely manner, rely on the advantages of production capacity to build "gelatin- Collagen-'collagen + terminal series'" and "gelatin-capsules-'collagen + terminal series'" industrial chain integrated development model, creating multi-track vertical integrated products, jointly building and sharing brands and channels, leading China's collagen industry develop. We will strive to diversify our income structure and become a leading brand of domestic collagen, and strive to build a comprehensive enterprise group in the sub-sectors of the big health industry, reflecting economies of scale, platform and brand benefits.